nanOss Strataâ„¢ is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity and enhance the stimulation of cellular activity
BELGRADE, Mont. , Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic...
Total Revenue of $33.3 Million Increased 19% Year-over-Year
Launch further expands Xtant's biologics product portfolio to include surgical wound closure
BELGRADE, Mont. , Nov. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal,...
BELGRADE, Mont. , Sept. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. Â (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...
Total Revenue of $35.4 Million Increased 18% Year-over-Year
BELGRADE, Mont. , Aug. 6, 2025 /PRNewswire/ --Â Xtant Medical Holdings, Inc. Â (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...
BELGRADE, Mont. , Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...
Full Year 2024 Revenue Growth of 28%